Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrin C Bergheanu

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Acta Cardiologica|January 12, 2010
Post-intervention IVUS is not predictive for very late in-stent thrombosis in drug-eluting stentsSandrin C Bergheanu, Bas L Van der Hoeven, Ayman K M Hassan, et al.
Chronobiology International|May 16, 2009
Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1Sandrin C Bergheanu, Douwe Pons, J Wouter Jukema, et al.
Disease Markers|July 8, 2011
Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarctionSandrin C Bergheanu, Arnoud van der Laarse, Johanna G van der Bom, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 31, 2009
In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization programAyman K M Hassan, Su San Liem, Frank van der Kley, et al.
CNS Neuroscience & Therapeutics|February 14, 2019
Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trialKawita M S Kanhai, Jenny A Nij Bijvank, Yorick L Wagenaar, et al.
British Journal of Clinical Pharmacology|November 16, 2020
Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part studyMarcus P J van Diemen, Ellen P Hart, Anthony Abbruscato, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Acta Cardiologica|January 12, 2010
Post-intervention IVUS is not predictive for very late in-stent thrombosis in drug-eluting stentsSandrin C Bergheanu, Bas L Van der Hoeven, Ayman K M Hassan, et al.
Chronobiology International|May 16, 2009
Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1Sandrin C Bergheanu, Douwe Pons, J Wouter Jukema, et al.
Disease Markers|July 8, 2011
Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarctionSandrin C Bergheanu, Arnoud van der Laarse, Johanna G van der Bom, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 31, 2009
In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization programAyman K M Hassan, Su San Liem, Frank van der Kley, et al.
CNS Neuroscience & Therapeutics|February 14, 2019
Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trialKawita M S Kanhai, Jenny A Nij Bijvank, Yorick L Wagenaar, et al.
British Journal of Clinical Pharmacology|November 16, 2020
Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part studyMarcus P J van Diemen, Ellen P Hart, Anthony Abbruscato, et al.
Pageof 2